Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ABBV save search
AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation
Published: 2021-02-19 (Crawled : 17:00) - biospace.com/
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.16%
H: 0.44%
C: -1.15%
EOLS | $11.9 -1.57% -1.6% 650K
|
Health Technology
|
| O: 48.18%
H: 39.59%
C: 15.83%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-03-25 (Crawled : 15:49) - fda.gov
PFE A | $25.91 0.19% -0.04% 34M
|
Health Technology
|
| O: 0.11%
H: 0.39%
C: 0.06%
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
|
| O: 0.46%
H: 1.46%
C: 1.15%
BMY | $48.51 0.48% 0.0% 12M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: -0.33%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.16%
H: 1.21%
C: 0.95%
SUPN | $30.01 -0.76% -0.77% 370K
|
Health Technology
|
| O: -0.32%
H: 5.23%
C: 4.43%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.89%
H: 0.5%
C: 0.41%
OTIC | $0.077
|
Health Technology
|
| O: -1.88%
H: 2.3%
C: 0.0%
OMER | $3.36 -10.64% -11.9% 420K
|
Health Technology
|
| O: -1.44%
H: 3.5%
C: 2.24%
GILD | $67.76 -1.3% -1.31% 7.7M
|
Health Technology
|
| O: 0.67%
H: 0.15%
C: -1.22%
BMRN S | $91.51 -0.77% -0.78% 1.9M
|
Health Technology
|
| O: -0.72%
H: 1.06%
C: 0.76%
BCRX | $4.68 -1.89% -1.92% 2.5M
|
Health Technology
|
| O: -4.08%
H: 7.03%
C: 6.04%
AMGN | $265.505 -0.66% -0.67% 1.7M
|
Health Technology
|
| O: 0.64%
H: 0.2%
C: -0.32%
Cabaletta Bio Appoints Biopharmaceutical Leader Scott Brun, M.D. to Board of Directors
Published: 2021-06-28 (Crawled : 16:00) - biospace.com/
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.25%
H: 0.75%
C: -0.23%
ABT | $108.89 -0.2% 0.04% 4.6M
|
Health Technology
|
| O: 0.24%
H: 2.98%
C: 2.4%
CABA | $16.16 -5.11% -5.38% 1M
|
Health Technology
|
| O: 1.87%
H: 8.33%
C: 6.04%
biopharma
Global $500+ Mn Neurotrophic Keratitis Markets, 2023-2028: Empowering Vision Health - Neurotrophic Keratitis Market on the Rise
Published: 2023-08-25 (Crawled : 17:00) - prnewswire.com
NVS | $94.41 0.95% 0.0% 1.4M
|
Health Technology
|
| O: 0.67%
H: 0.37%
C: 0.26%
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.11%
H: 0.44%
C: -0.22%
KALA | $7.2 1.1% 24K
|
Health Technology
|
| O: -1.31%
H: 0.85%
C: 0.67%
BBIO | $25.8 -3.84% -3.99% 1.9M
|
Health Technology
|
| O: 0.71%
H: 5.34%
C: 4.95%
health global market
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-21 (Crawled : 00:00) - fda.gov
PFE A | $25.91 0.19% -0.04% 34M
|
Health Technology
|
| O: 0.18%
H: 1.54%
C: 1.39%
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
|
| O: 0.25%
H: 2.13%
C: 1.63%
BMY | $48.51 0.48% 0.0% 12M
|
Health Technology
|
| O: 0.21%
H: 0.83%
C: 0.33%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.5%
H: 1.37%
C: 0.91%
XERS | $1.86 -2.62% -2.69% 1.8M
|
Health Technology
|
| O: 0.24%
H: 0.73%
C: -4.13%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.17%
C: -0.13%
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 3.98%
C: -1.33%
OMER | $3.36 -10.64% -11.9% 420K
|
Health Technology
|
| O: 1.39%
H: 0.79%
C: 0.33%
GILD | $67.76 -1.3% -1.31% 7.7M
|
Health Technology
|
| O: 0.57%
H: 0.86%
C: 0.54%
BCRX | $4.68 -1.89% -1.92% 2.5M
|
Health Technology
|
| O: 0.5%
H: 4.88%
C: 4.7%
AMGN | $265.505 -0.66% -0.67% 1.7M
|
Health Technology
|
| O: 0.4%
H: 0.53%
C: 0.25%
Hyperhidrosis Treatment Market to Reach USD 950.7 Million, Globally, by 2031 at 5.1% CAGR: Allied Market Research
Published: 2022-10-13 (Crawled : 12:00) - prnewswire.com
ROIV | $10.85 -0.82% -0.83% 4.7M
|
Manufacturing
|
| O: -2.94%
H: 7.46%
C: 7.23%
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
|
| O: -1.68%
H: 4.47%
C: 4.07%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -2.34%
H: 4.74%
C: 4.55%
treatment research market
Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance
Published: 2022-01-10 (Crawled : 13:30) - biospace.com/
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
IRWD | $7.795 -1.08% -1.09% 2.5M
|
Health Technology
|
| O: -3.79%
H: 4.65%
C: 4.29%
Vitiligo Therapeutics Market - Information on Key Vendors Including (Alkem Laboratories Ltd., Bausch Health Companies Inc., Canixa Life Sciences, and more)
Published: 2022-08-25 (Crawled : 11:00) - prnewswire.com
TEVJF | $12.37 -24.22% 380
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
ALPMF | $9.48 43.47% 1.7K
|
Health Technology
|
| O: 1.55%
H: 0.1%
C: 0.1%
ALPMY | $9.55 -1.11% 300K
|
Manufacturing
|
| O: 1.04%
H: 0.62%
C: 0.34%
VTRS | $11.32 -0.09% -0.09% 4.4M
|
Health Technology
|
| O: 0.0%
H: 0.49%
C: 0.1%
BAX | $40.04 -0.72% -0.6% 3M
|
Health Technology
|
| O: 0.55%
H: 1.56%
C: 1.51%
BHC | $8.63 -1.48% 0.0% 3.2M
|
Health Technology
|
| O: 0.95%
H: 6.02%
C: 3.95%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.62%
H: 0.57%
C: 0.4%
AMGN | $265.505 -0.66% -0.67% 1.7M
|
Health Technology
|
| O: 0.62%
H: 0.02%
C: -0.13%
companies health life therapeutics market
The Global ELISA Market to Showcases Growth at a Significant CAGR of ~6% by 2027 | DelveInsight
Published: 2023-04-06 (Crawled : 14:20) - prnewswire.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 1.36%
H: 2.91%
C: 2.91%
CRL | $235.93 -2.24% 0.0% 460K
|
Commercial Services
|
| O: -0.08%
H: 0.55%
C: 0.52%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.0%
H: 0.86%
C: 0.47%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
EXAS | $65.35 -10.42% -11.63% 3.1M
|
Health Technology
|
| O: -0.82%
H: 3.93%
C: 3.85%
global growth market
The Galien Foundation Debuts 2021 Prix Galien USA Nominees in "Best Biotechnology Product," "Best Pharmaceutical Agent," "Best Medical Technology" and "Best Digital Health Solution" Categories
Published: 2021-07-20 (Crawled : 14:00) - prnewswire.com
TAK | $13.18 -1.42% 0.0% 1.8M
|
Health Technology
|
| O: 0.83%
H: 0.53%
C: -0.06%
NVO | $123.9 -0.49% 0.23% 2.9M
|
Health Technology
|
| O: -1.23%
H: 0.87%
C: 0.31%
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: 0.01%
H: 2.34%
C: 0.93%
GKOS M | $96.84 -1.42% 0.0% 340K
|
Health Technology
|
| O: -10.48%
H: 0.13%
C: -4.92%
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
|
| O: 0.37%
H: 1.17%
C: 0.01%
BSX | $67.44 -0.93% 0.0% 6.5M
|
Health Technology
|
| O: 0.22%
H: 4.07%
C: 3.56%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.11%
H: 1.89%
C: 0.43%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.29%
H: 1.02%
C: 0.78%
REGN | $898.33 -0.7% -0.71% 650K
|
Health Technology
|
| O: 0.52%
H: 0.92%
C: -0.18%
KPTI | $1.155 -5.33% -5.63% 810K
|
Health Technology
|
| O: 0.22%
H: 3.66%
C: 3.66%
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: 0.13%
H: 2.21%
C: -0.39%
GILD | $67.76 -1.3% -1.31% 7.7M
|
Health Technology
|
| O: 0.13%
H: 2.12%
C: 1.23%
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: 0.25%
H: 3.02%
C: 2.77%
biotech technology iot
Ironwood Pharmaceuticals Reports Second Quarter 2022 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand
Published: 2022-08-04 (Crawled : 13:00) - biospace.com/
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.29%
H: 0.34%
C: -2.23%
IRWD | $7.795 -1.08% -1.09% 2.5M
|
Health Technology
|
| O: -0.98%
H: 3.78%
C: 3.42%
linzess year
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
MS 3 d | $86.99 0.93% -0.26% 9.5M
|
Finance
|
| O: 0.28%
H: 0.9%
C: 0.72%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.35%
H: 3.4%
C: 3.17%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 81.82%
H: 0.0%
C: 0.0%
elahere abbvie cancer tumor acquire therapy
AbbVie Submits Supplemental New Drug Application to U.S. FDA for cariprazine (VRAYLAR®) for the Adjunctive Treatment of Major Depressive Disorder
Published: 2022-02-22 (Crawled : 14:30) - biospace.com/
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -1.93%
H: 3.61%
C: 3.05%
vraylar new drug treatment fda order application drug major depressive disorder
AbbVie Reports Second-Quarter 2023 Financial Results
Published: 2023-07-27 (Crawled : 15:00) - biospace.com/
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 2.13%
H: 4.77%
C: 3.02%
abbvie financial results
Genmab and AbbVie Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) From Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL)
Published: 2022-04-13 (Crawled : 22:00) - globenewswire.com
GNMSF | $291.12 3.83% 300
|
Health Technology
|
| O: -0.14%
H: 3.21%
C: 1.5%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.69%
H: 3.81%
C: 2.83%
GMAB | $29.51 0.85% 0.85% 500K
|
Health Technology
|
| O: -0.86%
H: 2.28%
C: -0.08%
cd20 duobody topline trial phase 1
AbbVie and Genmab Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) from Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL)
Published: 2022-04-13 (Crawled : 23:00) - prnewswire.com
GNMSF | $291.12 3.83% 300
|
Health Technology
|
| O: -0.14%
H: 3.21%
C: 1.5%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.69%
H: 3.81%
C: 2.83%
GMAB | $29.51 0.85% 0.85% 500K
|
Health Technology
|
| O: -0.86%
H: 2.28%
C: -0.08%
cd20 duobody topline trial phase 1
AbbVie to Host First-Quarter 2022 Earnings Conference Call
Published: 2022-04-14 (Crawled : 12:20) - prnewswire.com
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.69%
H: 3.81%
C: 2.83%
conference
Microbiome Global Market to Reach $940 Million by 2025 at a CAGR of 25%
Published: 2022-09-01 (Crawled : 16:00) - prnewswire.com
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.13%
H: 2.93%
C: 2.83%
global market
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.48%
H: 1.56%
C: 1.48%
IRWD | $7.795 -1.08% -1.09% 2.5M
|
Health Technology
|
| O: -5.63%
H: 7.34%
C: 2.81%
year pharmaceuticals ironwood financial
Vascular Endothelial Growth Factor (VGEF) Inhibitors Market: 36% Market Growth to Originate from North America | Technavio
Published: 2022-05-17 (Crawled : 06:00) - prnewswire.com
AZNCF | $138.88 -4.19% 960
|
Health Technology
|
| O: 4.22%
H: 0.0%
C: -2.05%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
VTRS | $11.32 -0.09% -0.09% 4.4M
|
Health Technology
|
| O: 0.54%
H: 3.32%
C: 2.78%
NVS | $94.41 0.95% 0.0% 1.4M
|
Health Technology
|
| O: 1.63%
H: 0.0%
C: 0.0%
BHC | $8.63 -1.48% 0.0% 3.2M
|
Health Technology
|
| O: 2.79%
H: 0.0%
C: 0.0%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.5%
H: 0.64%
C: 0.19%
AZN | $68.75 -0.26% -0.26% 7.6M
|
Health Technology
|
| O: 3.17%
H: 0.0%
C: 0.0%
AMGN | $265.505 -0.66% -0.67% 1.7M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
america growth market
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.